65,437 trials
Erectile Dysfunction
Primary: The Study's Primary Objective Will Assess the Change in Penile Length. — 1.14; 0.99; 1.04; 0.94 cm
Lung Cancer Prevention
Primary: Change in Urinary 8-hydroxydeoxyguanosine Levels — 2.36; 5.20; -1.08 ng/mg creatinine
Diabetes
Primary: MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) Across the Overall Tested Glucose Range — 2.7; 10.8; 6.4 Percent Difference
Type 2 Diabetes Mellitus
Primary: Proportion of Patients Reaching HbA1c <7% After 52 Weeks of Treatment Without Confirmed or Severe Hypoglycaemia. — 37.9; 38.2; 39.2; 33.3 percentage of participants
Stress Urinary Incontinence
Primary: Percentage of Participants With at Least 50% Reduction in 24-hour Pad Weight From Baseline to 6 Months — 85.4 percentage of participants — p=<0.0001
Non-small Cell Lung Cancer
Primary: Overall Survival — 12.55; 13.40 months — p=0.94896
Fallopian Tube Cancer · Ovarian Sarcoma · Ovarian Stromal Cancer
Primary: Acute Toxicity Rate — 6 percentage of participants
Dry Eye Syndrome
Primary: Tear Film Evaporation Rate — 26.0 10^-7g/cm^2/sec
Anthrax
Primary: Percentage of Subjects Achieving a TNA Response of a Predefined Threshold Value at Day 63 (5 Weeks Following the Third Vaccination on Day 28). — 71.2; 68.5; 73.9; 76.7…
Bowel Incontinence
Primary: Co-primary Effectiveness Endpoint: A Relative Percentage Change in Episodes of Accidental Bowel Leakage (ABL) Determined by Comparing Treatment Results to Pre-treatment…
Transient Tachypnea of the Newborn
Primary: Duration of Respiratory Support — 45; 42 hours
Ventilator Associated Pneumonia
Primary: Effectiveness of Chlorhexidine Gluconate Oral Care for Trauma Patients — 30; 29 participants
Myopia
Primary: Overall Comfort — 8.5; 8.6 Units on a scale
Attention Deficit Hyperactivity Disorder
Primary: Feasibility of Double-blind, Sham-controlled Design #1. Recruitment Number — 26; 13 participants
Biliary Tract Cancer · Gallbladder Cancer · Cancer Of The Extrahepatic Bile Duct
Primary: Progression Free Survival — 105; 114; 148 days